Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aros Applied Biotechnology was a Danish contract research organization (CRO) specializing in genomic services and biobanking for the life sciences industry. Founded in 2000 and headquartered in Aarhus, the company provided a range of services including DNA/RNA extraction, genotyping, and gene expression analysis using advanced platforms like Affymetrix and Illumina. Aros was particularly noted for its GLP-compliant biobanking services, offering secure storage and management of biological samples for clinical trials. The company served a global client base, including major pharmaceutical companies and academic research institutions. In November 2013, the company was acquired by Eurofins Scientific, a world leader in bioanalytical testing. Following the acquisition, Aros's operations were integrated into the Eurofins Genomics division to strengthen its presence in the clinical and pharmaceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aros Applied Biotechnology.